ARLENE BARRETT: Open Payments
NPI 1366750739 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 16 payments from 8 companies in 2025. Trend: 2023 $286 · 2024 $181 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $367 |
| LivaNova USA, Inc. | 5 | $191 |
| UCB, Inc. | 3 | $126 |
| Amneal Pharmaceuticals LLC | 1 | $125 |
| Eisai Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| Lilly USA, LLC | 1 | $123 |
Products named: ZEPOSIA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, CREXONT, Leqembi, REXULTI, WAINUA, Fintepla, Briviact.
Industry payments across FL — which companies pay providers there.
